Sensus Healthcare (NASDAQ:SRTS) Stock Passes Below Fifty Day Moving Average – What’s Next?

Sensus Healthcare, Inc. (NASDAQ:SRTS) crossed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $3.53 and traded as low as $2.70. Sensus Healthcare shares last traded at $2.73, with a volume of 27,028 shares.

Analyst Ratings Changes

SRTS has been the subject of a number of analyst reports. Citigroup restated a “buy” rating on shares of Sensus Healthcare in a report on Friday, May 8th. Wall Street Zen cut Sensus Healthcare from a “sell” rating to a “strong sell” rating in a report on Saturday, May 9th. Weiss Ratings restated a “sell (d)” rating on shares of Sensus Healthcare in a report on Tuesday, April 21st. Finally, Alliance Global Partners started coverage on shares of Sensus Healthcare in a research note on Friday, March 6th. They set a “buy” rating and a $7.50 price target on the stock. Five equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $6.88.

Sensus Healthcare Trading Up 0.7%

The stock has a market cap of $44.94 million, a PE ratio of -5.81 and a beta of 1.09. The company’s 50 day moving average is $3.53 and its 200-day moving average is $4.01.

Sensus Healthcare (NASDAQ:SRTS) last released its quarterly earnings results on Thursday, May 7th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by ($0.04). Sensus Healthcare had a negative return on equity of 15.79% and a negative net margin of 34.50%.The firm had revenue of $3.39 million for the quarter, compared to analysts’ expectations of $5.32 million.

Institutional Investors Weigh In On Sensus Healthcare

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Opes Wealth Management LLC acquired a new position in Sensus Healthcare during the 3rd quarter worth $50,000. XTX Topco Ltd acquired a new position in Sensus Healthcare during the 4th quarter worth $77,000. Jane Street Group LLC acquired a new position in Sensus Healthcare during the 4th quarter worth $79,000. Mindset Wealth Management LLC grew its holdings in Sensus Healthcare by 28.1% during the 3rd quarter. Mindset Wealth Management LLC now owns 50,100 shares of the company’s stock worth $157,000 after acquiring an additional 11,000 shares in the last quarter. Finally, Ingalls & Snyder LLC acquired a new position in Sensus Healthcare during the 4th quarter worth $219,000. Hedge funds and other institutional investors own 25.30% of the company’s stock.

Sensus Healthcare Company Profile

Sensus Healthcare, Inc is a medical technology company specializing in the development, manufacture and commercialization of superficial radiation therapy (SRT) systems. The company’s SRT devices utilize low-energy X-rays to treat a range of dermatological and oncological conditions, most notably non-melanoma skin cancers such as basal cell carcinoma and squamous cell carcinoma, as well as benign lesions including keloids. By delivering targeted radiation to superficial tissue layers, Sensus Healthcare’s systems aim to provide an alternative to surgical excision or systemic therapies, offering clinicians a non-invasive treatment option for eligible patients.

The company’s flagship products include the SRT-100™ and SRT-100+™ platforms, which feature handheld applicators, adjustable energy settings and integrated safety controls.